Pandemic influenza in a southern hemisphere setting: the experience in Peru from May to September, 2009

J Gomez1, Cv Munayco, Jc Arrasco

  • 1Direccion General de Epidemiologia (General Directorate of Epidemiology), Peru Ministry of Health, Lima, Peru. james.fielding@mh.org.au <james.fielding@mh.org.au>

Insights

Peru experienced the 2009 pandemic H1N1 influenza with 8,381 confirmed cases and a 1.71% fatality rate. The impact was not severe, but preparedness for future waves is crucial.

Area of Science:

  • Public Health
  • Epidemiology
  • Virology

Background:

  • Peru documented its experience with the 2009 pandemic H1N1 influenza.
  • The first case was confirmed on May 9, 2009, in a returning traveler.

Purpose of the Study:

  • To describe Peru's experience with the 2009 pandemic H1N1 influenza.
  • To analyze surveillance data for confirmed cases, incidence rates, and fatality.

Main Methods:

  • Utilized four primary surveillance systems: sentinel surveillance for influenza-like illness and severe acute respiratory infections, pediatric respiratory infection surveillance, and case/cluster surveillance.
  • Virological surveillance monitored influenza and other respiratory viruses.

Main Results:

  • By September 27, 2009, 8,381 cases were confirmed, with incidence rates of 4.4 and 4.1 per 10,000 in the 0-9 and 10-19 age groups, respectively.
  • A total of 143 fatal cases were reported between EW 26-37, yielding a case fatality rate of 1.71%.
  • The peak occurred in EW 30 with 37 deaths.

Conclusions:

  • The overall impact of the pandemic in Peru was not severe, and healthcare systems were not overwhelmed.
  • Despite a mild impact, future pandemic waves necessitate ongoing preparedness.

Related Concept Videos

Influenza01:27

Influenza

Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
Infectious Diseases and Their Occurrence01:28

Infectious Diseases and Their Occurrence

Infectious diseases appear in populations through various transmission patterns, influenced by pathogen characteristics, population immunity, environmental conditions, and social behavior. Understanding these patterns is essential for effective public health surveillance and intervention. These categories—sporadic, outbreak, epidemic, pandemic, and endemic—help frame the nature and scope of disease events.Sporadic diseases occur irregularly and infrequently, without a predictable temporal or...
Malaria01:29

Malaria

Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...
Vaccinations01:51

Vaccinations

Overview